Eastport Healthcare Inc Machias Center
-
Services:
- Naloxone and overdose education
- Discharge Planning
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Buprenorphine maintenance
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- Marital/couples counseling
- Substance use disorder education
- Individual counseling
- Health education services other than HIV/AIDS or hepatitis
- Family counseling
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Trauma-related counseling
- Substance use disorder counseling
- Relapse prevention
- Telemedicine/telehealth therapy
- Anger management
- Cognitive behavioral therapy
- Adults
- Children/Adolescents
- Private non-profit organization
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Payment assistance (check with facility for details)
- Sliding fee scale (fee is based on income and other factors)
- National Committee for Quality Assurance (NCQA)
- Federally Qualified Health Center
- This facility administers/prescribes medication for alcohol use disorder
- Vaping not permitted
- Male
- Female
- No formal relationship with prescribing entity
- Treatment for gambling disorder
- Sign language services for the deaf and hard of hearing
- Mental health services
- Social skills development
- Suicide prevention services
- Integrated primary care services
- Cash or self-payment
- Federal, or any government funding for substance use treatment programs
- Private health insurance
- IHS/Tribal/Urban (ITU) funds
- Medicare
- Federal military insurance (e.g., TRICARE)
- State-financed health insurance plan other than Medicaid
- Medicaid
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Hepatitis B (HBV) vaccination
- Hepatitis A (HAV) vaccination
- STD testing
- Breathalyzer or blood alcohol testing
- TB screening
- Drug or alcohol urine screening
- Testing for Hepatitis B (HBV)
- Drug and alcohol oral fluid testing
- Testing for Hepatitis C (HCV)
- Metabolic syndrome monitoring
- HIV testing
- Clients with co-occurring mental and substance use disorders
- Criminal justice (other than DUI/DWI)/Forensic clients
- Recovery coach
- Screening for tobacco use
- Comprehensive mental health assessment
- Interim services for clients
- Screening for substance use
- Screening for mental disorders
- Comprehensive substance use assessment
- Smoking not permitted
- Medications for pre-exposure to prophylaxis
- Non-nicotine smoking/tobacco cessation
- Nicotine replacement
- Naltrexone (oral)
- Buprenorphine (extended-release, injectable)
- Naltrexone (extended-release, injectable)
- Medications for HIV treatment
- Clonidine
- Disulfiram
- Acamprosate (Campral®)
- Buprenorphine without naloxone
- Buprenorphine with naloxone
- Medication for mental disorders
Transitional Services
Type of Opioid Treatment
Education and Counseling Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Treatment Approaches
Age Groups Accepted
Facility Operation (e.g., Private, Public)
Opioid Medications used in Treatment
Payment Assistance Available
License/Certification/Accreditation
Type of Alcohol Use Disorder Treatment
Facility Vaping Policy
Gender Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Other Services
Language Services
Ancillary Services
Payment/Insurance/Funding Accepted
Type of Care
Medical Services
Testing
Special Programs/Groups Offered
Recovery Support Services
Assessment/Pre-treatment
Facility Smoking Policy
Pharmacotherapies






